Safety and Effectiveness of Lurasidone in Patients with Schizophrenia: A 12-Week, Open-Label Extension Study-Reference-Cited by-同舟云学术

Safety and Effectiveness of Lurasidone in Patients with Schizophrenia: A 12-Week, Open-Label Extension Study

Published:2021-08 Issue: Volume:Volume 17 Page:2683-2695
ISSN:1178-2021
Container-title:Neuropsychiatric Disease and Treatment
language:en
Short-container-title:NDT

Author:

Iyo Masaomi^ORCID,Ishigooka Jun,Nakamura Masatoshi^ORCID,Sakaguchi Reiko,Okamoto Keisuke,Mao Yongcai,Tsai Joyce,Fitzgerald Alison,Takai Kentaro^ORCID,Higuchi Teruhiko

Publisher

Informa UK Limited

Reference46 articles.

1. World Health Organization. Schizophrenia fact sheet; 2016. Available from: https://www.who.int/news-room/fact-sheets/detail/schizophrenia. Accessed January 11, 2021.

2. The Lifetime Risk of Suicide in Schizophrenia

3. A Systematic Review of Mortality in Schizophrenia

4. Pattern of mortality in a sample of Maryland residents with severe mental illness

5. Occupational functioning, symptoms and neurocognition in patients with psychotic disorders: investigating subgroups based on social security status

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effect of Lurasidone on Life Engagement in Schizophrenia: Post-Hoc Analysis of the JEWEL Study;Neuropsychiatric Disease and Treatment;2024-07

2. The Role of Lurasidone in Managing Depressive Symptoms in People with Schizophrenia: A Review;Brain Sciences;2024-02-28

3. Effect of Lurasidone on Social Functioning in Schizophrenia;The Journal of Clinical Psychiatry;2024-01-31

4. A Systematic Review on the Effectiveness of Antipsychotic Drugs on the Quality of Life of Patients with Schizophrenia;Brain Sciences;2023-11-10

5. Lurasidone for the treatment of schizophrenia in adult and paediatric populations;Drugs in Context;2023-02-03